|
Volumn 26 Suppl 1, Issue , 2001, Pages 36-41
|
Optimal platelet inhibition therapy in unstable angina pectoris and after coronary interventions;Optimierte Plättcheninhibitortherapie bei instabiler Angina pectoris und nach Koronarinterventionen.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
CLOPIDOGREL;
DRUG DERIVATIVE;
FIBRINOGEN RECEPTOR;
FIBRINOLYTIC AGENT;
HEPARIN;
TICLOPIDINE;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DRUG ANTAGONISM;
DRUG COMBINATION;
HEART INFARCTION;
HUMAN;
MULTICENTER STUDY;
TIME;
TRANSLUMINAL CORONARY ANGIOPLASTY;
UNSTABLE ANGINA PECTORIS;
ANGINA, UNSTABLE;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTICOAGULANTS;
ASPIRIN;
CLINICAL TRIALS;
DRUG THERAPY, COMBINATION;
FIBRINOLYTIC AGENTS;
HEPARIN;
HUMANS;
MULTICENTER STUDIES;
MYOCARDIAL INFARCTION;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
TICLOPIDINE;
TIME FACTORS;
|
EID: 0035319936
PISSN: 03409937
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|